A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)
PHASE1
This multicenter, open-label, Phase I study will evaluate the safety, effic...
A Study to Assess Patient-Reported Quality of Life and Effectiveness on Control of Bleeding in Adult Participants With Heavy Menstrual Bleeding Due to Uterine Fibroids Taking Oral Oriahnn Capsules
N/A
Uterine Fibroids (UF) are noncancerous (benign) tumors that commonly occur ...
Status
Terminated
Location
IQVIA RDS, Inc.
Start Date
2021-10-05
Trial ID
NCT05026502
A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG
PHASE2
The purpose of this study is to evaluate the safety and preliminary efficac...